SQZ Biotechnologies Company (SQZB)
OTCMKTS · Delayed Price · Currency is USD
0.0240
-0.0001 (-0.41%)
Mar 6, 2026, 9:30 AM EST

SQZB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending
Mar '26 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Market Capitalization
122251716--
Market Cap Growth
-4.00%-91.31%-65.01%---
Enterprise Value
-0158825--
Last Close Price
0.020.748.9328.98--
PS Ratio
0.061.019.2534.11--
PB Ratio
0.380.382.025.63--
P/TBV Ratio
0.380.382.025.63--
EV/Sales Ratio
-05.8339.29--
Debt / Equity Ratio
11.420.480.560.370.72-
Net Debt / Equity Ratio
6.00-0.63-0.59-0.97-0.95-1.70
Net Debt / EBITDA Ratio
-0.190.491.092.481.705.53
Net Debt / FCF Ratio
-0.150.430.892.781.57-5.40
Asset Turnover
0.130.130.120.110.15-
Quick Ratio
1.152.934.413.822.625.07
Current Ratio
1.373.124.533.912.665.10
Return on Equity (ROE)
-203.37%-87.74%-54.73%-54.38%-53.03%-
Return on Assets (ROA)
-41.14%-29.07%-18.80%-16.64%-15.99%-
Return on Capital Employed (ROCE)
-290.00%-97.10%-35.60%-27.50%-30.00%-21.70%
Earnings Yield
-10122.11%-364.62%-27.43%-7.05%--
FCF Yield
-10532.41%-385.76%-33.02%-6.19%--
Buyback Yield / Dilution
-3.56%-4.47%-410.54%-216.92%-13.12%-
Source: S&P Capital IQ. Standard template. Financial Sources.